Table 2.
RCT comparing EUS-FNA and EUS-FNB for diagnosis of pancreatic cancers
| Study | Year of study | Total no of patients | Accuracy/diagnostic yield, FNA versus FNB (%) | Sensitivity, FNA versus FNB (%) | Specificity, FNA versus FNB (%) |
| Cheng et al80 | 2018 | 408 | 80 vs 91.4* | NA | NA |
| Van Riet et al82 | 2019 | 608 | 87 vs 78* | 90 vs 82* | 96 vs 91 |
| Wang et al83 | 2016 | 408 | 80 vs 93 | NA | NA |
| Vanbiervliet et al81 | 2014 | 80 | 92.5 vs 90 | NA | NA |
| Lee et al84 | 2014 | 118 | 94.8 vs 98.3 | 94.6 vs 98.2 | 100 vs 100 |
| Strand et al85 | 2014 | 32 | 93.8 vs 28.1* | NA | NA |
*Statistically significant data.
EUS, endoscopic ultrasound; FNA, fine-needle aspiration; FNB, fine-needle biopsy; NA, not applicable; RCT, randomised control trial.